Literature DB >> 16272720

Intercalation compound of diclofenac sodium with layered inorganic compounds as a new drug material.

Tomoko Tajima1, Noriko Suzuki, Yoshiteru Watanabe, Yasushi Kanzaki.   

Abstract

The intercalation reaction of diclofenac sodium (DFS) with layered inorganic compounds, gamma-titanium phosphate (gamma-TiP), proton type titanium oxide (H-TiO2) and sodium type synthetic mica (Na-TSM), was examined on. The direct reaction of DFS in ethanol-water mixed solvent resulted in the large amount accommodation of DFS. The amount of intercalated DFS was the order of gamma-TiP>H-TiO2>Na-TSM corresponding to the order of acidity. The intercalation using phospholiopids was also examined to assist the intercalation reaction. However, the amount of intercalated DFS was rather small in comparison with those in the direct reaction. DFS accommodated in gamma-TiP dissolved into neutral and basic buffer solution stoichiometry while scarcely dissolved in the acidic solution. The mechanism of the intercalation and reverse dissolution was successfully accounted according to the ion-exchange mechanism between Na+ in DFS and H+ in gamma-TiP. The dissolution from tablet of DFS/gamma-TiP intercalation compound was examined by using a disintegrator. It was found that the dissolution rate appropriately controlled by mixing the disintegrator. The present results suggested the different possibilities in the clinical field to use layered inorganic compounds such as drug delivery system (DDS).

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16272720     DOI: 10.1248/cpb.53.1396

Source DB:  PubMed          Journal:  Chem Pharm Bull (Tokyo)        ISSN: 0009-2363            Impact factor:   1.645


  1 in total

1.  Nanoencapsulation of insulin into zirconium phosphate for oral delivery applications.

Authors:  Agustín Díaz; Amanda David; Riviam Pérez; Millie L González; Adriana Báez; Stacey E Wark; Paul Zhang; Abraham Clearfield; Jorge L Colón
Journal:  Biomacromolecules       Date:  2010-09-13       Impact factor: 6.988

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.